Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente
Autor(a) principal: | |
---|---|
Data de Publicação: | 2012 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11 |
Resumo: | While new more potent and complex pharmaceutical agents are becoming available, increasing demands on doctors and the health care system, the increase of drug related morbidity and mortality throughout the world and rising costs related with the incorrect use of medicines make it clear that the identification of a practitioner who is available to focus on the management of all of a patient’s medicines would be an important asset to the future of human health. Medicines are precious, but patients need to learn how to use them. It is possible that this will be one of the advantages that the pharmacist, as a medicine specialist, will bring to the health system, i.e. the promotion of the rational use of medicines as laid down in legislation. The correct use of medicines will significantly decrease the negative outcomes of phar- macotherapy, namely untreated health problems, ineffective treatment and unsafe treatment.Pharmaceutical care is a patient-centered philosophy of assistential practice in which the pharmacist, as a health care team member, has responsibilities in patient medication. There are pharmaceutical services that monitor the process of the use of medicines from a preventive standpoint, identifying risk factors and acting within their constraints – dispensing, preventable morbidity indicators, medication review – and there are pharmaceutical services that monitor the outcomes from a reactive standpoint, identifying negative clinical outcomes and acting on their causes – pharmacotherapy follow-up, disease management. The clinical pharmacist will have to develop new competencies in communication, information retrieval, critical analysis, ethical behavior, teamwork and leadership. And, more than ever, the clinical pharmacist will have to be technically competent, which requires solid training in cellular biology, biochemistry, anatomophysiology, physiopathology, pharmacology and pharmacotherapy. The assistential pharmacist will have to learn to systematize and to register its action in each type of service carried out. The main barrier that he will have to overcome will be his own mind. This will not only provide new ways of boosting the professional satisfaction of the clinical pharmacist but will also provide concrete answers to the real situations of patients, who will ultimately receive better care. |
id |
RCAP_8ad979059e6fa4704899b9080f6f6e20 |
---|---|
oai_identifier_str |
oai:ojs.actafarmaceuticaportuguesa.com:article/11 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Necessidades reais de implementação de novos serviços farmacêuticos centrados no doenteNecessidades reais de implementação de novos serviços farmacêuticos centrados no doentepharmaceutical carepharmaceutical servicespharmacotherapynegative clinical outcomespatient.cuidados farmacêuticosserviços farmacêuticosfarmacoterapiaresultados clínicos negativosdoente.While new more potent and complex pharmaceutical agents are becoming available, increasing demands on doctors and the health care system, the increase of drug related morbidity and mortality throughout the world and rising costs related with the incorrect use of medicines make it clear that the identification of a practitioner who is available to focus on the management of all of a patient’s medicines would be an important asset to the future of human health. Medicines are precious, but patients need to learn how to use them. It is possible that this will be one of the advantages that the pharmacist, as a medicine specialist, will bring to the health system, i.e. the promotion of the rational use of medicines as laid down in legislation. The correct use of medicines will significantly decrease the negative outcomes of phar- macotherapy, namely untreated health problems, ineffective treatment and unsafe treatment.Pharmaceutical care is a patient-centered philosophy of assistential practice in which the pharmacist, as a health care team member, has responsibilities in patient medication. There are pharmaceutical services that monitor the process of the use of medicines from a preventive standpoint, identifying risk factors and acting within their constraints – dispensing, preventable morbidity indicators, medication review – and there are pharmaceutical services that monitor the outcomes from a reactive standpoint, identifying negative clinical outcomes and acting on their causes – pharmacotherapy follow-up, disease management. The clinical pharmacist will have to develop new competencies in communication, information retrieval, critical analysis, ethical behavior, teamwork and leadership. And, more than ever, the clinical pharmacist will have to be technically competent, which requires solid training in cellular biology, biochemistry, anatomophysiology, physiopathology, pharmacology and pharmacotherapy. The assistential pharmacist will have to learn to systematize and to register its action in each type of service carried out. The main barrier that he will have to overcome will be his own mind. This will not only provide new ways of boosting the professional satisfaction of the clinical pharmacist but will also provide concrete answers to the real situations of patients, who will ultimately receive better care. Novos fármacos mais potentes e complexos, menor disponibilidade de médicos e menor acessibilidade ao serviço de saúde, morbilidade e mortalidade relacionadas com medicamentos sempre a aumentar e custos significativos relacionados com o uso incorrecto dos medicamentos justificam plenamente um profissional focado apenas na gestão de toda a medicação do doente. O medicamento é um bem precioso, mas os doentes necessitam de aprender a utilizá-lo. Porventura será essa uma das mais-valias que o farmacêutico, enquanto especialista do medicamento, poderá aportar actualmente ao sistema de saúde: a promoção do uso racional do medicamento, tal como inscrito na legislação em vigor. Uma correcta utilização do medicamento diminuirá significativamente os resultados negativos da farmacoterapia, que se podem manifestar quer como problema de saúde não tratado quer como inefectividade ou insegurança. Os cuidados farmacêuticos correspondem a uma filosofia de actuação assistencial centrada no doente em que o farmacêutico, integrado na equipa de saúde, assume as suas responsabilidades perante a medicação. Concretiza-se em serviços farmacêuticos que, numa atitude preventiva, identificam e actuam sobre factores de risco existentes durante o processo de uso dos medicamentos – dispensa farmacêutica, indicadores de morbilidade prevenível, revisão da medicação – e em serviços que, numa atitude reactiva, identificam resultados negativos e actuam sobre as suas causas – acompanhamento farmacoterapêutico, gestão da doença. O farmacêutico clínico terá de desenvolver novas competências: comunicação, busca de informação, sentido crítico, comportamento ético, trabalho em equipa, liderança. E terá, mais do que nunca, de ser tecnicamente competente: sólida formação em biologia celular, bioquímica, anatomofisiologia, fisiopatologia, farmacologia e farmacoterapia. Terá ainda de aprender a sistematizar e a registar a sua actuação consoante o tipo de serviço prestado. A principal barreira a vencer será a da sua própria mentalidade. Estes não serão apenas novos caminhos de realização profissional: serão respostas concretas a situações reais dos doentes, que desta forma serão melhor cuidados. Acta Farmacêutica Portuguesa2012-12-30T00:00:00Zjournal articleinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11oai:ojs.actafarmaceuticaportuguesa.com:article/11Acta Farmacêutica Portuguesa; v. 2 n. 1 (2013); 15-202182-3340reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11/69Castel-Branco, M. M.Caramona, M. M.Fernandez-Llimos, F.Figueiredo, I. V.info:eu-repo/semantics/openAccess2022-09-05T12:29:44Zoai:ojs.actafarmaceuticaportuguesa.com:article/11Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T14:59:51.848717Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente |
title |
Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente |
spellingShingle |
Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente Castel-Branco, M. M. pharmaceutical care pharmaceutical services pharmacotherapy negative clinical outcomes patient. cuidados farmacêuticos serviços farmacêuticos farmacoterapia resultados clínicos negativos doente. |
title_short |
Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente |
title_full |
Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente |
title_fullStr |
Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente |
title_full_unstemmed |
Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente |
title_sort |
Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente |
author |
Castel-Branco, M. M. |
author_facet |
Castel-Branco, M. M. Caramona, M. M. Fernandez-Llimos, F. Figueiredo, I. V. |
author_role |
author |
author2 |
Caramona, M. M. Fernandez-Llimos, F. Figueiredo, I. V. |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Castel-Branco, M. M. Caramona, M. M. Fernandez-Llimos, F. Figueiredo, I. V. |
dc.subject.por.fl_str_mv |
pharmaceutical care pharmaceutical services pharmacotherapy negative clinical outcomes patient. cuidados farmacêuticos serviços farmacêuticos farmacoterapia resultados clínicos negativos doente. |
topic |
pharmaceutical care pharmaceutical services pharmacotherapy negative clinical outcomes patient. cuidados farmacêuticos serviços farmacêuticos farmacoterapia resultados clínicos negativos doente. |
description |
While new more potent and complex pharmaceutical agents are becoming available, increasing demands on doctors and the health care system, the increase of drug related morbidity and mortality throughout the world and rising costs related with the incorrect use of medicines make it clear that the identification of a practitioner who is available to focus on the management of all of a patient’s medicines would be an important asset to the future of human health. Medicines are precious, but patients need to learn how to use them. It is possible that this will be one of the advantages that the pharmacist, as a medicine specialist, will bring to the health system, i.e. the promotion of the rational use of medicines as laid down in legislation. The correct use of medicines will significantly decrease the negative outcomes of phar- macotherapy, namely untreated health problems, ineffective treatment and unsafe treatment.Pharmaceutical care is a patient-centered philosophy of assistential practice in which the pharmacist, as a health care team member, has responsibilities in patient medication. There are pharmaceutical services that monitor the process of the use of medicines from a preventive standpoint, identifying risk factors and acting within their constraints – dispensing, preventable morbidity indicators, medication review – and there are pharmaceutical services that monitor the outcomes from a reactive standpoint, identifying negative clinical outcomes and acting on their causes – pharmacotherapy follow-up, disease management. The clinical pharmacist will have to develop new competencies in communication, information retrieval, critical analysis, ethical behavior, teamwork and leadership. And, more than ever, the clinical pharmacist will have to be technically competent, which requires solid training in cellular biology, biochemistry, anatomophysiology, physiopathology, pharmacology and pharmacotherapy. The assistential pharmacist will have to learn to systematize and to register its action in each type of service carried out. The main barrier that he will have to overcome will be his own mind. This will not only provide new ways of boosting the professional satisfaction of the clinical pharmacist but will also provide concrete answers to the real situations of patients, who will ultimately receive better care. |
publishDate |
2012 |
dc.date.none.fl_str_mv |
2012-12-30T00:00:00Z |
dc.type.driver.fl_str_mv |
journal article info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11 oai:ojs.actafarmaceuticaportuguesa.com:article/11 |
url |
https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11 |
identifier_str_mv |
oai:ojs.actafarmaceuticaportuguesa.com:article/11 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11 https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11/69 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Acta Farmacêutica Portuguesa |
publisher.none.fl_str_mv |
Acta Farmacêutica Portuguesa |
dc.source.none.fl_str_mv |
Acta Farmacêutica Portuguesa; v. 2 n. 1 (2013); 15-20 2182-3340 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799129870961213440 |